openPR Logo
Press release

Noldus teams up with Institut Pasteur to deliver new software for behavioral neuroscience research

05-17-2023 01:47 PM CET | Science & Education

Press release from: Noldus Information Technology bv

Noldus teams up with Institut Pasteur to deliver new software

Noldus Information Technology and Institut Pasteur have collaborated on the development of an innovative solution for automatic tracking and analysis of social behavior in mice. Today we announce the result of this joint effort: a new tool for behavioral neuroscience research, combining Live Mouse Tracker (LMT) and EthoVision XT software. This integration facilitates and enhances the analysis and visualization of LMT data.

Live Mouse Tracker was developed by the Human Genetics and Cognitive Functions unit of Institut Pasteur. LMT is a system for real-time behavioral analysis of groups of mice in a dedicated hardware setup. Through the use of RFID, computer vision and machine learning, LMT is able to track multiple mice, extract their individual and social behaviors and assign these parameters to individual animals.

EthoVision XT, under continuous development by Noldus Information Technology since its market introduction in 1993, is the most widely used video tracking software for the analysis of behavior, movement and activity of laboratory animals. With the release of version 17.5, LMT data can be imported and analyzed directly in EthoVision XT, which brings all of the functionality and power of EthoVision XT to LMT users. EthoVision XT offers easy organization of LMT trials, which in turn enables data filtering, nesting and analysis. Furthermore, LMT data can be visualized in EthoVision's graphs and integrated data plots.

Lucas Noldus, CEO of Noldus Information Technology, comments: "With this collaboration, the innovative development of Institut Pasteur and Noldus IT's many years of experience in developing behavior analysis software, are combined to make a step forward in the measurement of social interactions in groups of mice. This will help to advance research on neurodevelopmental conditions and disorders with a social component in which mouse models are used, such as autism, ADHD and schizophrenia."

The Institut Pasteur, a non-profit foundation with recognized charitable status set up by Louis Pasteur in 1887, is today an internationally renowned center for biomedical research. In the pursuit of its mission to tackle diseases in France and throughout the world, the Institut Pasteur operates in four main areas: research, public health, training, and development of research applications. Professor Thomas Bourgeron, head of the Human Genetics and Cognitive Functions unit, adds "I am happy to see our collaboration result in a novel tool that will make analysis of mouse social behavior more accessible to neuroscientists around the world".

Noldus Information Technology, established in 1989 and headquartered in Wageningen, the Netherlands, develops software and integrated solutions for research on animal and human behavior. Noldus systems are used in more than 12.000 research groups at universities, institutes and companies around the world.

Visit www.noldus.com and discover the solutions and resources needed for your next project.

Visit www.livemousetracker.org to learn more about LMT and its applications.

Nieuwe Kanaal 5
Wageningen, the Netherlands
press@noldus.nl

Noldus Information Technology, established in 1989 and headquartered in Wageningen, the Netherlands, develops software and integrated solutions for research on animal and human behavior. Noldus systems are used in more than 12.000 research groups at universities, institutes and companies around the world.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Noldus teams up with Institut Pasteur to deliver new software for behavioral neuroscience research here

News-ID: 3056577 • Views:

More Releases for Pasteur

DTaP Vaccine Market | GlaxoSmithKline, Merck, Sanofi Pasteur, Ltd
The global dtap vaccine market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the dtap vaccine market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants. From the perspective of market dynamics, this report explores the factors driving the growth of the
Yellow Fever Vaccines Market 2021-2028 Analysis by Trends | Key Companies - Sano …
Global Yellow Fever Vaccines Market Size was estimated at USD 129 million in 2021 and is projected to reach USD 172.1 million by 2028, exhibiting a CAGR of 4.21% during the forecast period. Report Overview: Global Yellow Fever Vaccines Market Report 2022 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market
Travelers Vaccines Market to See Massive Growth by 2021-2026 | Sanofi Pasteur, M …
Global Travelers Vaccines Market Size, Status and Forecast 2021 The Global Travelers Vaccines Market Research Report 2021-2026 is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides comprehensive data that enhances the
Travelers Vaccines Market 2027: Top Players & COVID-19 Impact Analysis - Merck , …
Travelers Vaccines Market Reports presents an in-depth assessment of this report including market drivers, challenges, enabling technologies, vertical market opportunities, applications, key trends, standardization, opportunities, future roadmap, value chain, ecosystem player profiles and strategies. The report mainly studies the size, recent trends and development status of the Travelers Vaccines market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement
Travelers Vaccines Market 2018 to 2023 - GSK, Sanofi Pasteur, Pfizer, CNBG, Sano …
A report added to the rich database of Qurate Business Intelligence, titled “World Travelers Vaccines Market Research Report 2023 (Covering USA, Europe, China, Japan, India and etc)”, provides a 360-degree overview of the worldwide market. Approximations associated with the market values over the forecast period are based on empirical research and data collected through both primary and secondary sources. The authentic processes followed to exhibit various aspects of the market
Travelers Vaccines Market 2022 Trends, Global Opportunities, Top Manufacturer- S …
Vaccines are biological preparations that provide immunity to a particular disease by stimulating the immune system. The vaccines can be administered orally, intra-nasally, or through injections in both adults and children. Government bodies such as the CDC and the NHS have mandated the vaccination of emigrants traveling to disease-prone areas to prevent the spread of infectious agents through them. The Players mentioned in our report GSK, Sanofi Pasteur, Pfizer, CNBG, Sanofi